Cargando…
Targeting Non-Oncogene Addiction: Focus on Thyroid Cancer
Thyroid carcinoma (TC) is the most common malignancy of endocrine organs with an increasing incidence in industrialized countries. The majority of TC are characterized by a good prognosis, even though cases with aggressive forms not cured by standard therapies are also present. Moreover, target ther...
Autores principales: | Anania, Maria Chiara, Di Marco, Tiziana, Mazzoni, Mara, Greco, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017043/ https://www.ncbi.nlm.nih.gov/pubmed/31947935 http://dx.doi.org/10.3390/cancers12010129 |
Ejemplares similares
-
Targeting Non-Oncogene Addiction for Cancer Therapy
por: Chang, Hae Ryung, et al.
Publicado: (2021) -
Drugging the addict: non‐oncogene addiction as a target for cancer therapy
por: Nagel, Remco, et al.
Publicado: (2016) -
Immuno-targeted combinations in oncogene-addicted non-small cell lung cancer
por: Listì, Angela, et al.
Publicado: (2019) -
Role of STAT3 in In Vitro Transformation Triggered by TRK Oncogenes
por: Miranda, Claudia, et al.
Publicado: (2010) -
Oncogenic RAS-induced senescence in human primary thyrocytes: molecular effectors and inflammatory secretome involved
por: Vizioli, Maria Grazia, et al.
Publicado: (2014)